Overcoming Acquired Resistance Mechanisms in BRAF+ mCRC

Video

Following their discussion on data from the BEACON and ANCHOR trials, experts look towards the future and the potential of overcoming acquired resistance mechanisms in the treatment of BRAF-mutated metastatic colorectal cancer.

Related Videos
Amin Nassar, MD
Kara N. Maxwell, MD, PhD
Kian-Huat Lim, MD, PhD
Pashtoon Murtaza Kasi, MD, MS
Michael Iglesia, MD, PhD
Katrina S. Pedersen, MD, MS, associate professor, John T. Milliken Department of Medicine, Division of Oncology, Medical Oncology program leader, cofounder, Young Onset Colorectal Cancer Program, Washington University School of Medicine in St. Louis, Siteman Cancer Center
Jin Qian, PhD
A panel of 4 experts on colorectal cancer
Heinz-Josef Lenz, MD, FACP
A panel of 4 experts on colorectal cancer